Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$451,788
-$75,048 QoQ
Shares Held
18,762
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,827
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Oliver Luxxe Assets LLC holds $24,335,082 across 7 Drug Manufacturers - General names. PFE ranks #4 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
45,272 | $8,584,476 | |
| 2 | ABBV |
AbbVie Inc.
|
31,485 | $7,922,885 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
52,852 | $6,677,321 | |
| 4 | PFE |
Pfizer Inc
This page
|
18,762 | $451,788 | |
| 5 | JNJ |
Johnson & Johnson
|
1,059 | $268,954 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 | |
| 7 | AMGN |
Amgen Inc
|
590 | $213,650 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $451,788 | 18,762 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $526,836 | 18,762 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $467,223 | 18,764 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $502,567 | 19,724 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $455,978 | 18,811 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $476,670 | 18,811 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $499,055 | 18,811 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $532,785 | 18,410 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $521,155 | 18,626 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $515,123 | 18,563 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $534,428 | 18,563 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $615,734 | 18,563 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $693,728 | 18,913 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $810,002 | 19,853 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,557,388 | 88,942 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,889,782 | 88,889 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,606,394 | 87,858 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,543,335 | 87,760 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,295,367 | 89,676 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,856,964 | 89,676 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,381,661 | 86,355 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $3,159,908 | 87,218 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,049,193 | 82,836 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,437,832 | 93,674 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,972,367 | 90,898 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,005,878 | 92,092 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||